Mind the gap in kidney care: Translating what we know into what we do

Valerie A Luyckx1,2,3, Katherine R Tuttle4,5, Dina Abdellatif6

  • 1Department of Public and Global Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.

PubMed

Insights

It takes too long to implement new kidney disease treatments. Early diagnosis and treatment of kidney disease and its risk factors like hypertension and diabetes are crucial but often delayed due to numerous barriers.

Area of Science:

  • Nephrology
  • Public Health
  • Health Services Research

Background:

  • Significant delays exist in translating kidney disease treatments from clinical evidence to practice.
  • Effective interventions for preventing and delaying kidney disease are underutilized.
  • Many individuals with kidney disease risk factors (hypertension, diabetes) and kidney disease itself remain undiagnosed or undertreated.

Purpose of the Study:

  • To highlight the critical need to accelerate the implementation of evidence-based kidney disease treatments.
  • To identify barriers hindering early diagnosis and appropriate management of kidney disease.
  • To advocate for maximizing opportunities for early kidney disease detection and treatment, particularly at the primary care level.

Main Methods:

  • This is a conceptual and evidence-based review, not a primary research study.
  • Analysis of existing literature and guidelines on kidney disease prevention and management.
  • Identification and categorization of barriers to care across patient, clinician, health system, and societal levels.

Main Results:

  • A substantial gap persists between established knowledge and clinical practice in kidney disease care.
  • Early stages of kidney disease are often asymptomatic, leading to delayed diagnosis.
  • Numerous systematic barriers impede timely and effective kidney disease diagnosis and treatment.

Conclusions:

  • Urgent action is required to reduce the 17-year average delay in implementing kidney disease treatments.
  • Addressing barriers at all levels is imperative for preserving and improving global kidney health.
  • Early intervention, starting in primary care, is essential to prevent severe outcomes like kidney failure and death.

Related Concept Videos

Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
294
Internal Anatomy of the Kidney01:12

Internal Anatomy of the Kidney

The kidneys are essential organs in the human body, performing a myriad of tasks that maintain homeostasis and overall health.
Anatomical Position and Dimensions
The kidneys are retroperitoneal organs positioned against the posterior abdominal wall on either side of the spine, roughly between the twelfth thoracic and third lumbar vertebrae. Each kidney is typically 10-12 cm long, 5-6 cm wide, and 3-4 cm thick, weighing about 150 grams.
Renal Cortex
The outermost region of the kidney is the...
1.6K
Renal Drug Excretion: Tubular Secretion01:28

Renal Drug Excretion: Tubular Secretion

Active tubular secretion is a robust, energy-demanding process that utilizes carrier systems to transport drugs into renal tubules. The active renal secretion systems include the organic anion transporter (OAT) for weak acids and the organic cation transporter (OCT) for weak bases. Structurally similar drugs can compete for the same transporter, potentially leading to drug accumulation and toxicity. However, this principle can be exploited therapeutically. One example is probenecid (Probalan),...
175